Myomo, Inc. hosted its Investor & Analyst Day, where senior executives provided an in-depth review of the company's business model and discussed long-range aspirational financial metrics. The event included a tour of the new headquarters and manufacturing facility in Burlington, Mass.
During the event, Myomo stated its aspiration to achieve $100 million in annual revenue by 2028. This target is accompanied by aspirational gross margins of 70% to 72% and an EBITDA margin of 15% to 20%.
The company also set aspirational goals for its O&P channel, aiming for $20 million in revenue by 2028, and for international revenue, targeting $15 million annually by 2028. Myomo indicated a cash flow breakeven revenue of $17 million to $18 million on a quarterly basis.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.